UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Central Pacific Financial
CPF
$996M
| $2.25M | ﹤0.01% |
74,273
-42,860
| -37% | -$1.26M |
|
1702
Tandem Diabetes Care
TNDM
$1.63B
| $2.24M | ﹤0.01% |
184,895
-84,008
| -31% | -$1.14M |
|
1703
Mineralys Therapeutics
MLYS
$2.41B
| $2.24M | ﹤0.01% |
59,042
+34,638
| +142% | +$749K |
|
1704
Healthcare Services Group
HCSG
$1.44B
| $2.24M | ﹤0.01% |
132,982
-107,504
| -45% | -$1.6M |
|
1705
Seaboard Corp
SEB
$3.99B
| $2.23M | ﹤0.01% |
612
-597
| -49% | -$2.08M |
|
1706
Astronics
ATRO
$3.7B
| $2.23M | ﹤0.01% |
58,691
-59,084
| -50% | -$1.8M |
|
1707
Intuitive Machines
LUNR
$2.64B
| $2.21M | ﹤0.01% |
210,099
-139,809
| -40% | -$1.42M |
|
1708
Bitdeer Technologies
BTDR
$2.11B
| $2.2M | ﹤0.01% |
128,713
-118,297
| -48% | -$1.66M |
|
1709
LegalZoom.com
LZ
$932M
| $2.19M | ﹤0.01% |
210,641
-155,983
| -43% | -$1.56M |
|
1710
GlobalFoundries
GFS
$27.9B
| $2.18M | ﹤0.01% |
60,958
-61,390
| -50% | -$2.19M |
|
|
AGNT
1711
AGNT Inc
AGNT
$714M
| $2.17M | ﹤0.01% |
203,568
-72,071
| -26% | -$762K |
|
|
AD
1712
Array Digital Infrastructure
AD
$3.01B
| $2.17M | ﹤0.01% |
43,328
-23,730
| -35% | -$1.47M |
|
1713
Adaptive Biotechnologies
ADPT
$4.04B
| $2.16M | ﹤0.01% |
144,635
-122,258
| -46% | -$1.49M |
|
1714
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $2.16M | ﹤0.01% |
55,519
-49,186
| -47% | -$1.6M |
|
1715
Comstock Resources
CRK
$4.23B
| $2.15M | ﹤0.01% |
108,514
-112,528
| -51% | -$2.08M |
|
1716
IAMGOLD
IAG
$10.4B
| $2.15M | ﹤0.01% |
166,215
-453,219
| -73% | -$3.97M |
|
1717
Royal Bank of Canada
RY
$292B
| $2.15M | ﹤0.01% |
14,576
-1,605,445
| -99% | -$221M |
|
1718
TriCo Bancshares
TCBK
$1.83B
| $2.15M | ﹤0.01% |
48,306
-40,819
| -46% | -$1.78M |
|
1719
QCR Holdings
QCRH
$1.71B
| $2.14M | ﹤0.01% |
28,358
-25,532
| -47% | -$1.92M |
|
1720
Napco Security Technologies
NSSC
$1.42B
| $2.13M | ﹤0.01% |
49,554
-40,459
| -45% | -$1.4M |
|
1721
Westamerica Bancorp
WABC
$1.36B
| $2.13M | ﹤0.01% |
42,524
-40,841
| -49% | -$2.02M |
|
1722
Madison Square Garden
MSGE
$3.75B
| $2.12M | ﹤0.01% |
46,901
-55,782
| -54% | -$2.26M |
|
1723
Appian
APPN
$2.54B
| $2.11M | ﹤0.01% |
69,095
-51,011
| -42% | -$1.53M |
|
1724
Embecta
EMBC
$276M
| $2.1M | ﹤0.01% |
148,751
-81,060
| -35% | -$1.03M |
|
1725
Gorman-Rupp
GRC
$2.19B
| $2.1M | ﹤0.01% |
45,167
-28,693
| -39% | -$1.19M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.